Candel Therapeutics, Inc.

NASDAQ:CADL

Biotechnology

Healthcare
$5.32 +0.56%

+$0.05 today

Market cap
$417.33M
Beta
-0.48
P/E (TTM)
-9.2
EPS (TTM)
-$0.87
52W Low $4.35High $9.57

Volume 1.39M

Average 1.82M

Balance Sheet

Inspect the capital base behind the business.

Assets

$125.19M

FY 2025 · Annual

+17.2% YoY

Liabilities

$73.27M

FY 2025 · Annual

+80.7% YoY

Equity

$51.92M

FY 2025 · Annual

-21.7% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents82.64M70.06M35.41M102.65M119.73M
Short-term Investments00000
Net Receivables00000
Inventory00000
Other Current Assets2.3M1.89M1.38M00
Total Current Assets84.95M71.95M36.8M103.8M119.73M
Property, Plant & Equipment (Net)3.84M5.48M4.02M2.73M0
Goodwill00000
Intangible Assets00000
Long-term Investments424K266K00416K
Tax Assets0828K000
Other Non-current Assets00382K329K5.05M
Total Non-current Assets4.26M6.57M4.4M3.06M5.46M
Total Assets89.21M78.52M41.2M106.87M125.2M
Account Payables1.59M380K422K237K1.13M
Short-term Debt0464K8.89M9.9M445K
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities1.68M2.12M2.34M22.11M7.42M
Total Current Liabilities5.36M5.62M14.18M37.53M9M
Long-term Debt560K20.85M12.38M2.6M1.46M
Deferred Tax Liabilities0828K000
Deferred Revenue (Non-current)0144K000
Other Non-current Liabilities19.15M1.88M916K062.82M
Total Non-current Liabilities19.71M25.19M14.27M3.01M64.28M
Total Liabilities25.07M30.81M28.46M40.54M73.27M
Common Stock286K290K290K469K550K
Retained Earnings(80.3M)(99.09M)(137.03M)(192.21M)(230.39M)
Accumulated OCI(89.21M)00(0)0
Other Stockholders Equity00000
Minority Interest00000
Total Equity64.14M47.71M12.75M66.33M51.92M
Total Debt560K22.8M22.76M13.47M1.9M
Net Debt(82.08M)(47.26M)(12.65M)(89.18M)(117.83M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$194.8M
Other Current$2.9M
Total Current Assets$197.8M
PP&E (Net)$3.6M
Other Non-current$524.0K
Total Non-current Assets$4.2M
Total Assets$201.9M

Analysis

Selected assets total $201.9M for Latest. The largest visible component is Cash & Equivalents at $194.8M, about 96.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
424B5424B5 filingNov 12, 2026
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 12, 2026
8-KCurrent reportNov 12, 2026
4Statement of changes in beneficial ownershipNov 5, 2026

How much cash does CADL have?

Candel Therapeutics, Inc. (CADL) reported $119.73M in cash and equivalents in fiscal 2025.

How much debt does CADL carry?

Candel Therapeutics, Inc. (CADL) reported $1.90M of total debt, with net debt of -$117.83M.